In order to examine the influence of obesity on metabolic disorder and liver pathogenesis of the Fatty Liver Shionogi (FLS) 
Abstract:
In order to examine the influence of obesity on metabolic disorder and liver pathogenesis of the Fatty Liver Shionogi (FLS) mouse, which develops hereditary fatty liver and spontaneous liver tumors, we established a new congenic strain named FLS- 
Introduction
Fatty liver is defined as abnormal accumulation of triglyceride within hepatocytes. In humans, fatty liver is a common hepatic reaction to chronic alcohol ingestion, and is often seen in persons with obesity, type 2 diabetes mellitus, and hyperlipidemia. It is well known that chronic alcohol intake is a risk factor of severe he--Original-patic disorders including steatohepatitis, cirrhosis, and carcinogenesis. On the other hand, non-alcoholic fatty liver has not attracted much attention until recently because the condition was thought to be a reversible benign disease. In 1980, Ludwig et al. reported that alcoholic steatohepatitis-like lesions were observed in persons who did not consume alcohol, and that form of steatohepatitis was named non-alcoholic steatohepatitis (NASH) [17] . NASH is microscopically characterized by hepatic steatosis, lobular inflammation, ballooning degeneration of hepatocytes, Mallory bodies, and pericellular fibrosis [18] . Furthermore, recent studies have suggested that NASH may progress to fibrosis, cirrhosis, and hepatocellular carcinoma [2, 9, 25, 34] . The prevalence of NASH is 2.1-6.3% in the general populations, and in many patients, NASH is associated with obesity, diabetes mellitus, and hyperlipidemia [3, 22, 27] . NASH has become an important health problem with the increase of obesity and type 2 diabetes mellitus in developed countries.
Previously, we reported the establishment of the Fatty Liver Shionogi (FLS) mouse [30] . This strain of mouse shows lipid deposition in hepatocytes from the neonatal stage, and the degree of liver lipid (mainly triglyceride) accumulation increases as the mouse grows without obesity. In addition to lipid deposition, steatohepatitis-like lesions with micro-abscesses and infiltration of mononuclear cells is observed in FLS mice. A preliminary genetic cross study suggested that the fatty liver formation in the FLS mice is caused by a complex polygenic trait. Interestingly, aged FLS mice frequently develop hepatocellular adenoma, carcinoma, and peliosis hepatis [31] . Therefore, the FLS mouse might be a useful animal model for human NASH.
C57BL/6J-Lep ob /Lep ob mice are often used as a model animal for human obesity and type 2 diabetes mellitus. The mutation of the Lep ob gene coding the leptin protein causes remarkable hyperphagia and obesity [35] . Leptin, which is secreted from white adipose tissue with the increase of the body fat, suppresses of feeding behavior and increases energy consumption through leptin receptors in the hypothalamus [7] . C57BL/6JShi mice were used in this study as a control lean mouse. All mice were kept in our specific pathogenfree facilities, which are free of the following microorganisms: HVJ, MHV, Bordetella bronchiseptica, Corynebacterium kutscheri, Mycoplasma pulmonis, Tyzzer's organism (Clostridium piliforme), Pasteurella pneumotropica, Salmonella sp., Pseudomonas aeruginosa, Staphylococus aureus, and Helicobacter hepaticus. The inside of the animal facilities was maintained at constant temperature (23 ± 1°C) and humidity (60 ± 5%) with lighting for 12 h daily (light from 06:00 to 18:00). Mice were housed in polycarbonate cages with hardwood chip bedding. Commercial chow diet (CA-1; Clea Japan Inc., Tokyo, Japan) containing crude protein, 27%, and crude fat, 4.6%, and drinking tap water were available ad libitum. Chow was autoclaved at 121°C for 7 min, and drinking water was sterilized by filtration and UV light. All experiments in this study followed the Guidelines for Animal Experimentation of the Japanese Association for Laboratory Animal Science [15] .
Materials and Methods

Animals
Clinical characterizations
Body weights of mice used in this study were recorded until 60 weeks of age from 5 weeks of age. The appearance of glucosuria was monitored using Testape ® (Shionogi & Co., Ltd., Osaka, Japan) until 60 weeks of age from 3 weeks of age. The mice showing Testape ® values of 1+ (>100 mg/dl urine) or higher were diagnosed as having overt diabetes. Food consumption, water intake, and excreted urine volume were measured at 10 and 20 weeks of age, by placing the mice in stainless metabolic cages.
Plasma biochemical analysis
Mice were anesthetized by intraperitoneal administration of Nembutal ® (Abbott Laboratories, North Chicago, IL, USA) under the non-fasting condition at 10 weeks of age. Blood samples were collected in a heparinized syringe (between 09:00 and 10:00) from the heart. The plasma was immediately separated by centrifugation (10 min, 1,500 × g). The plasma triglyceride level was measured by an enzymatic method using a commercial kit, TrIGLYZYME-600 ® (Eiken Chemical, Tokyo, Japan). with human insulin as a standard. Plasma alanine transaminase (ALT) activity was measured using an automatic analyzer (model 705; Hitachi, Tokyo, Japan) with reagents from Wako Pure Chemical.
Measurement of liver lipids
Mice were sacrificed under anesthesia induced by administration of an overdose of Nembutal ® at 10 weeks of age. Livers were immediately removed, and weighed. Part of each liver was homogenized in distilled water, and the lipids were extracted by shaking in cold chloroform:methanol (v/v, 2:1), as described by Folch et al. [6] . Liver triglyceride, total cholesterol, and phospholipid contents were measured by enzymatic methods using commercial kits (Triglyceride-E, Cholesterol-E, and Phospholipid-C Test Wako ® ; Wako Pure Chemical).
Oral glucose tolerance test (OGTT)
At 10 and 20 weeks of age, female mice were orally administrated glucose (2 g/kg body weight) after overnight fasting. Blood samples from the infraorbital venous plexus were obtained consecutively at 0, 30, 60, 120, and 180 min after glucose administration, by a heparinized capillary. Plasma glucose level was measured by Glucose B-Test ® (Wako Pure Chemical).
Expression of leptin mRNA in adipose tissue
The mouse leptin oligonucleotide probe (5'-CAG TGA CCC TCT GCT TGG CGG ATA CCG ACT GCG TGT GTG A-3') for northern blot hybridization was established in an upstream region of the mutation point [35] . The probe was labeled with dIG-dUTP using dIG 3'-Tailing Kit (Boehringer Mannheim, Mannheim, Germany). Total rNA was extracted from periuterine white adipose tissue in 10-week-old mice, using RNeasy ® To- 
Statistical analysis
The data are expressed as mean ± SE. One-way analysis of variance (ANOVA) followed by Student's t-test or by Welch's t-test was used for statistical analysis of the data. The criterion for significance was taken as P<0.05.
Results
Establishment of the congenic strain
First The antisense oligonucleotide probe for leptin mrNA detected a single band (~4.1 kb) in northern bloting of total rNA from periuterine white adipose tissues ( The expression of leptin mrNA in FLS mice was slightly higher than in C57BL/6J/Shi mice. (Fig. 2B) . At this stage, the food consumption of lean FLS mice was 3-4 g (data not shown). At 20 weeks of age, the food consumption of both these obese mouse strains showed a tendency to decrease from the levels seen at 10 weeks. nodule was histologically classified as a hepatocellular adenoma (Fig. 6B) . The hepatocellular adenomas consisted of larger hepatocytes with round nuclei, which compressed adjacent hepatocytes. The adenoma cells had eosinophilic cytoplasm and nuclei of relatively constant size. The reddish cysts had the histological character of peliosis hepatis (Fig. 6C) . Peliosis hepatis shows a disrupted parenchymal structure in which a thin column of hepatocytes is sandwiched by dilated sinusoidal spaces lined by prominent endothelial cells. Hepatocellular carcinomas were observed in 18-month-old FLSLep ob /Lep ob mice. The hepatocellular carcinomas were a well-differentiated type with a trabecular structure of tumorous hepatocytes (Fig. 6d) . Hepatocellular carcinomas were occasionally found in adenomas (Fig. 6E) . The deposition of large lipid droplets tended to decrease with aging (Fig. 6F) . The B6-Lep ob /Lep ob mice showed no evidence of hepatic tumors.
Obesity-related characters
Diabetes-related characters
Discussion
Increase of obesity is an important human health problem in developed countries [26] . In the obese condition, the increasing insulin requirement of peripheral tissues due to excessive accumulation of body fat frequently progresses to insulin resistance. Fatty liver is observed in most obesity and type 2 diabetes mellitus patients, but its treatment has been neglected because it was thought to be a benign disease. In 1980, Ludwig et al. reported cases of steatohepatitis without excessive alcohol intake, and this form of steatohepatitis named non-alcoholic steatohepatitis (NASH). This finding indicated the possibility that fatty liver progresses to the hepatitis. recently, hepatic steatosis without chronic alcohol intake and a clear cause has been called non-alcoholic fatty liver disease (NAFLd) [5] . NAFLd includes various conditions such as simple steatosis, NASH, and hepatic fibrosis, which is characterized by the presence of hepatic fatty change. NASH is closely related to obesity and insulin resistance. It was reported that the moderate fatty liver, NASH, and cirrhosis were found in 100, 50, and 19% of the severe obese patients with diabetes mellitus, respectively [29] . Only a few patients with NAFLd eventually develop more severe liver diseases cirrhosis and hepatocellular carcinoma, but the risk increases in the presence of NASH. recent study have reported that many cases progress to liver cancer from NASH [10, 13, 28] . NASH has become an important health problem due to the increase of obesity and type 2 diabetes mellitus in developed countries.
We previously reported the establishment of FLS mouse [30] . The FLS mouse shows lipid (mainly triglyceride) accumulation in the liver from a young age. The results of a genetic cross study suggest that fatty liver formation in FLS mice is a complex polygenic trait [30] . Takahashi et al. suggested that apo C-III is a candidate causative factor of hypertriglycemia in FLS mice [32] . In addition to the lipid metabolism abnormalities in the liver and blood, steatohepatitis-like lesions including micro-abscesses and infiltration of mononuclear cells were observed in the liver of FLS mice. Interestingly, aged FLS mice frequently developed hepatic tumors including hepatocellular adenoma, carcinoma, and peliosis hepatis [31] . These findings suggest that the FLS mouse has potential as a model of steatohepatitis and hepato-carcinogenesis in human NASH. The relationship between NASH and carcinogenesis in FLS mice is not yet clear. However, Iwai et al. reported that FLS mice have the higher sensitivity to diethylnitrosamineinduced hepatocarcinogenesis than C3H and C57BL mice [14] . This finding suggests that FLS mice are susceptible to hepatic cancer by stimulation such as inflammation and dNA damage.
In the present study, we attempted to transfer the FLS mice develop hepatic tumors following steatohepatitis. The incidence of hepatic tumors in male FLS mice was 9% at 13-14 months of age [31] . The FLSLep ob /Lep ob mice also developed hepatic tumors, and their incidence was high compared with FLS mice at 12 months of age. The hepatic tumors were multiple in many cases. The whitish nodules were histologically classified as hepatocellular adenoma and/or carcinoma. Hepatocellular carcinomas were occasionally found in the center area of adenomas with aging. The hepatocellular carcinomas were a well-differentiated type with a trabecular structure of tumorous hepatocytes. In a preliminary study, 18-month-old male and female FLSLep ob /Lep ob mice had hepatic tumors with an incidence of 100%, a higher incidence than FLS mice (93% in males and 0% in females). Fat deposition in the nontumor area of livers of FLS-Lep ob /Lep ob and FLS mice with hepatic tumors tended to decrease. This finding resembles "burn-out NASH" in humans, in which fat deposition decreases at the time of the development of cirrhosis and hepatic cancer [24] . In humans, the development to the liver cancer from fatty liver has attracted attention. It is thought that the accumulation of dNA damage under chronic hepatic inflammation, as in NASH, induces carcinogenesis. The differences in tumor prevalence in FLS-Lep ob /Lep ob and FLS mice may be related to the degree of the fatty change and inflammation in the liver. Hepatitis C virus (HCV) infection is a major cause of chronic hepatitis, which eventually leads to hepatic carcinogenesis. Steatosis of the liver is a histological features of hepatitis C [1] . The transgenic expression of HCV core protein in mice has been reported to induce both hepatic steatosis and HCC, although inflammation in the liver was not observed in transgenic mice [19, 21] . Although the HCV core protein transgenic mice did not have inflammation, it was shown that production of reactive oxygen species (rOS) increased [20] . These findings suggest that chronic steatosis in the liver is also a risk for hepatocarcinogenesis, and the risk increases in the presence of chronic inflammation such as NASH. Recently, Horie et al. reported that the hepatocytespecific phosphatase and tensin homolog (PTEN) deficient mouse develops steatohepatitis and hepatocellular carcinoma. [12] . However, this mouse does not show obesity and insulin resistance, and has characteristics which are different from NASH in humans.
In 
